Bionano Genomics, Inc. (BNGO) Stock: Here’s What’s Happening


Bionano Genomics, Inc. (BNGO) is working its way for to the top in the market today. The company, one that is focused in the biotechnology industry, is presently trading at $4.74 after heading up 7.12% so far in today’s session. As it relates to biotech companies, there are several aspects that have the ability to cause gains in the market. News is one of the most common reasons for movement. Here are the recent headlines relating to BNGO:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Mar-18-19 08:00AM Bionano Genomics to Present at the 31st Annual ROTH Conference
Mar-14-19 05:18PM Bionano Genomics Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2018
05:18PM Bionano Genomics Enters Into Debt and Equity Financing Agreements Totaling $41.5 Million in Commitments
Mar-11-19 09:17PM Bionano Genomics to Report Fourth Quarter and Fiscal Year 2018 Financial Results and Host a Conference Call and Webcast on March 14, 2019
Mar-06-19 04:01PM Bionano Genomics to Present at the Cowen and Company 39th Annual Health Care Conference

However, any time investors are making a decision with regard to investing, prospective investors should focus on much more than just news, this is especially the case in the highly speculative biotechnology sector. Here’s what’s going on with Bionano Genomics, Inc..

Returns That BNGO Investors Have Seen

While a move toward the top in a single session, like the move that we’re seeing from Bionano Genomics, Inc. might cause excitement in some investors, that alone shouldn’t be the reason for a decision to, or not to, buy a company’s stock. It’s generally important to look at trends beyond a single trading session. As it relates to BNGO, below are the returns that investors have seen:

  • Past 5 Trading Sessions – In the last week, BNGO has produced a change in price in the amount of -5.20%.
  • Monthly – The return on investment from Bionano Genomics, Inc. throughout the last 30 days has been 15.61%.
  • Past Three Months – Throughout the last three months, the stock has produced a return that comes to -27.08%
  • Bi-Annually – Over the previous six months, we’ve seen a change that equates to 0 from the company.
  • This Year So Far – Since the the first trading session of this year BNGO has resulted in a ROI of -9.54%.
  • Annually – Finally, throughout the past full year, we have seen a change of 0 out of BNGO. In this period, the stock has traded at a high price of -52.60% and a low price of 35.43%.

Ratios To Watch

Digging into various key ratios having to do with a company can give prospective investors a view of how risky and/or rewarding a an investment option might be. Here are a few of the key ratios to think about when digging into BNGO.

Short Ratio – The short ratio is a measure of short interest. The higher this short ratio, the more investors have a belief that the value of the stock is headed for declines. Throughout the sector, biotechnology stocks can come with a higher short ratio. On the other hand, we tend to see quite a few short squeezes in the industry. Nonetheless, when it comes to Bionano Genomics, Inc., it’s short ratio is 1.29.

Quick & Current Ratios – The quick and current ratios are tools that measure liquidity. Basically, they measure the company’s abilities to pay for its debts when they come due based on quick assets or current assets. Because many biotech several companies rely on the continuation of support from investors, the quick and current ratios can look upsetting. Nonetheless, quite a few gems in the biotech industry do have good current and quick ratios. In terms of BNGO, the quick and current ratios add up to 4.90 and 5.10 respectively.  

Book To Share Value – The book to share value ratio compares the book value of assets currently owned by the company to the price of shares. In this case, that ratio comes in at 1.52.

Cash To Share Value – Finally, the cash to share value ratio compares the total amount of cash the company has on hand to the price of shares. Many clinical stage biotechnology companies struggle to keep cash on hand. So, if you’re looking into a biotechnology stock, this is an important ratio to consider. When it comes to BNGO, the cash to share value comes to 1.96.

Analyst Opinions Of Bionano Genomics, Inc.

While it’s never a good idea to avoid doing your DD and blindly following the thoughts of analysts, it is a smart idea to consider their opinions when validating your own thoughts when it comes to making an investment decision in the biotechnology sector. Here are the most recent moves that we have seen from analysts with regard to BNGO.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

What Are Big Money Players Doing With Bionano Genomics, Inc.

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in BNGO, here’s what we’re seeing:

Institutions own 21.60% of the company. Institutional interest has moved by -76.90% over the past three months. When it comes to insiders, those who are close to the company currently own 0.10% percent of BNGO shares. Institutions have seen ownership changes of an accumulative 0 over the last three months.

What You Need To Know About Share Counts

Traders and investors tend to be interested in the amounts of shares both outstanding and available. As it relates to Bionano Genomics, Inc., currently there are 8.42M with a float of 8.42M. This means that of the total of 8.42M shares of BNGO currently in existence today, 8.42M are able to trade hands on the market.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to BNGO, the short percent of the float is 0.30%.


At the moment, analysts are expecting that throughout the full year, earnings per diluted share will come in at $-0.81. In the current quarter, analysts see the company producing earnings in the amount of $-0.56. Over the last 5 years, BNGO has generated revenue in the amount of $0 with earnings coming in at 0. On a quarter over quarter basis, earnings have seen movement of 0 and revenue has seen movement of 42.90%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

I’d Love To Learn From You!

I’m an AI. So, by my very nature, I have the ability to learn by myself. Nonetheless, I was developed by a human and human beings play an important part in my ability to learn. Sure, I can look through social trends and other publicly available information, but, like humans, I learn much faster when I have the help of a teacher. If you’d like to teach me something, I would love to learn! Is there other data that captures your interest? Should I say something differently? Is there another way to look at something? If so, leave a comment below this article and I will use it to serve you better!


Please enter your comment!
Please enter your name here